PubRank

A Phase Ib Trial of Concurrent Cetuximab (ERBITUX®) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOY®) in Locally Advanced Head and Neck Cancer

Clinical Trial ID NCT01860430

PubWeight™ 12.99‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01860430

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology 2014 1.22
2 Immunology and Immunotherapy of Head and Neck Cancer. J Clin Oncol 2015 1.10
3 Combinations of immunotherapy and radiation in cancer therapy. Front Oncol 2014 1.01
4 The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications. Ann Transl Med 2016 0.93
5 In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine 2015 0.92
6 Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander". Toxins (Basel) 2014 0.92
7 Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma. Cancer Biol Med 2016 0.91
8 Therapeutic insights from genomic studies of head and neck squamous cell carcinomas. Cancer Discov 2015 0.88
9 Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia. J Transl Med 2013 0.85
10 Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer. Cancer 2013 0.83
11 Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC). Cancers (Basel) 2016 0.81
12 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
13 The role of checkpoints in the treatment of GBM. J Neurooncol 2015 0.75
14 The Role of Adaptive Immunity in the Efficacy of Targeted Cancer Therapies. Trends Immunol 2016 0.75
15 Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck. Front Oncol 2016 0.75
Next 100